Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsumei Urano

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
The Journal of Obstetrics and Gynaecology Research|July 13, 2018
The incidence and prognosis of thromboembolism associated with oral contraceptives: Age-dependent difference in Japanese populationKazuko Sugiura, Toshiyuki Ojima, Tetsumei Urano, et al.
Life Sciences|June 9, 2009
Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitroAki Tanaka, Yuko Suzuki, Kazuhiro Sugihara, et al.
Thrombosis Research|July 2, 2002
L-158,809 and (D-Ala(7))-angiotensin I/II (1-7) decrease PAI-1 release from human umbilical vein endothelial cellsMasaya Yoshida, Yasuhisa Naito, Tetsumei Urano, et al.
Blood|July 28, 2011
Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cellsYuko Suzuki, Hideki Yasui, Tomasz Brzoska, et al.
Plos One|February 6, 2013
Binding of thrombin-activated platelets to a fibrin scaffold through α(IIb)β₃ evokes phosphatidylserine exposure on their cell surfaceTomasz Brzoska, Yuko Suzuki, Hideo Mogami, et al.
Blood Advances|November 9, 2020
Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation systemYuko Suzuki, Hideto Sano, Liina Mochizuki, et al.
Journal of Hypertension|October 2, 2025
Effects of room temperature on home morning, evening, and sleep blood pressure: the Shizuoka studyYasuharu Tabara, Osamu Kushida, Etsuko Ozaki, et al.
FEBS Open Bio|July 16, 2016
Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cellsYuko Suzuki, Hideto Sano, Martyna Tomczyk, et al.
Annals of Vascular Surgery|December 4, 2017
Ectopic Expression of PCSK9 by Smooth Muscle Cells Contributes to Aortic DissectionYasunori Iida, Hiroki Tanaka, Hideto Sano, et al.
Current Drug Targets|October 6, 2022
COVID-19 and Thrombosis: Clinical AspectsTetsumei Urano, Atsushi Yasumoto, Kenji Yokoyama, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Obstetrics and Gynaecology Research|July 13, 2018
The incidence and prognosis of thromboembolism associated with oral contraceptives: Age-dependent difference in Japanese populationKazuko Sugiura, Toshiyuki Ojima, Tetsumei Urano, et al.
Life Sciences|June 9, 2009
Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitroAki Tanaka, Yuko Suzuki, Kazuhiro Sugihara, et al.
Thrombosis Research|July 2, 2002
L-158,809 and (D-Ala(7))-angiotensin I/II (1-7) decrease PAI-1 release from human umbilical vein endothelial cellsMasaya Yoshida, Yasuhisa Naito, Tetsumei Urano, et al.
Blood|July 28, 2011
Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cellsYuko Suzuki, Hideki Yasui, Tomasz Brzoska, et al.
Plos One|February 6, 2013
Binding of thrombin-activated platelets to a fibrin scaffold through α(IIb)β₃ evokes phosphatidylserine exposure on their cell surfaceTomasz Brzoska, Yuko Suzuki, Hideo Mogami, et al.
Blood Advances|November 9, 2020
Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation systemYuko Suzuki, Hideto Sano, Liina Mochizuki, et al.
Journal of Hypertension|October 2, 2025
Effects of room temperature on home morning, evening, and sleep blood pressure: the Shizuoka studyYasuharu Tabara, Osamu Kushida, Etsuko Ozaki, et al.
FEBS Open Bio|July 16, 2016
Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cellsYuko Suzuki, Hideto Sano, Martyna Tomczyk, et al.
Annals of Vascular Surgery|December 4, 2017
Ectopic Expression of PCSK9 by Smooth Muscle Cells Contributes to Aortic DissectionYasunori Iida, Hiroki Tanaka, Hideto Sano, et al.
Current Drug Targets|October 6, 2022
COVID-19 and Thrombosis: Clinical AspectsTetsumei Urano, Atsushi Yasumoto, Kenji Yokoyama, et al.
Pageof 9